The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticles
{{output}}
Chronic kidney disease (CKD) affects 15% of the US adult population. However, most clinically available drugs for CKD show low bioavailability to the kidneys and non-specific uptake by other organs which results in adverse side effects. Hence, a targeted, drug... ...
